Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy

ClinicalTrials.gov ID: NCT00851786

Public ClinicalTrials.gov record NCT00851786. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function

Study identification

NCT ID
NCT00851786
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
395 participants

Conditions and interventions

Interventions

  • ZOSTAVAX Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2009
Primary completion
Sep 21, 2011
Completion
Jan 2, 2012
Last update posted
Nov 3, 2021

2009 – 2012

United States locations

U.S. sites
43
U.S. states
20
U.S. cities
33
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35294-2050
University of Southern California CRS Los Angeles California 90033
UCLA CARE Center CRS Los Angeles California 90035
Stanford CRS Palo Alto California 94304-5350
Ucsd, Avrc Crs San Diego California 92103
Ucsf Aids Crs San Francisco California 94110
Harbor-UCLA Med. Ctr. CRS Torrance California 90502
University of Colorado Hospital CRS Aurora Colorado 80045
Denver Public Health CRS Denver Colorado 80204
Georgetown University CRS (GU CRS) Washington D.C. District of Columbia 20007
Univ. of Miami AIDS CRS Miami Florida 33136
The Ponce de Leon Center CRS Atlanta Georgia 30308-2012
Northwestern University CRS Chicago Illinois 60611
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
IHV Baltimore Treatment CRS Baltimore Maryland 21201
Johns Hopkins Adult AIDS CRS Baltimore Maryland 21287
Massachusetts General Hospital ACTG CRS Boston Massachusetts 02114
Brigham and Women's Hosp. ACTG CRS Boston Massachusetts 02115
Bmc Actg Crs Boston Massachusetts 02118
Beth Israel Deaconess Med. Ctr., ACTG CRS Boston Massachusetts 02215
Henry Ford Hosp. CRS Detroit Michigan 48202
Washington U CRS St Louis Missouri 63110
Cooper Univ. Hosp. CRS Camden New Jersey 08103
New Jersey Medical School- Adult Clinical Research Ctr. CRS Newark New Jersey 07103
Cornell CRS New York New York 10010
NY Univ. HIV/AIDS CRS New York New York 10016
HIV Prevention & Treatment CRS New York New York 10032
Univ. of Rochester ACTG CRS Rochester New York 14642
Bronx-Lebanon Hosp. Ctr. CRS The Bronx New York 10457
Chapel Hill CRS Chapel Hill North Carolina 27599
Duke Univ. Med. Ctr. Adult CRS Durham North Carolina 27710
Greensboro CRS Greensboro North Carolina 27401
Univ. of Cincinnati CRS Cincinnati Ohio 45267-0405
Case CRS Cleveland Ohio 44106
MetroHealth CRS Cleveland Ohio 44109
The Ohio State University Medical Center Columbus Ohio 43210
The Research & Education Group-Portland CRS Portland Oregon 97210
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania 19104
Thomas Jefferson Univ. Med. Ctr. CRS Philadelphia Pennsylvania 19107
Pitt CRS Pittsburgh Pennsylvania 15213-2582
The Miriam Hosp. ACTG CRS Providence Rhode Island 02906
Vanderbilt Therapeutics CRS Nashville Tennessee 37204
University of Washington AIDS CRS Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00851786, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00851786 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →